NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Browsing: Diagnostics Tech

LOS ANGELES (March 16, 2021) – XPRIZE announced today the five winning teams in the $6M XPRIZE Rapid Covid Testing competition to create high-quality, affordable COVID-19 testing to help society safely reopen and return to everyday activities. Chosen by an independent panel of judges, the grand prize winning solutions are radically affordable compared to what is currently available on the market; and are comparable to commercial offerings at measuring sensitivity, specificity and limit of detection, with a maximum turnaround time of 12 hours from sample to result.  The winning teams are: Reliable LFC, LLC, Antigen Testing, Carlsbad, United States ChromaCode,…

Mirimus is the parent company of SalivaClear, a polymerase chain reaction (PCR) testing system with a focus on serving schools and workplaces. The goal of SalivaClear is to help people across the nation return to school and work with a self-collection approach that is noninvasive and simple. Prior to the outbreak of the coronavirus, Mirimus was heavily involved in genome editing technologies, especially in regards to the synergization of RNAi and CRISPR technologies. Mirimus is also considered a world leader in PCR testing, which is seen as the “gold standard” of Covid-19 testing. SalivaClear is centered around three main…

One of the core metrics of accuracy for a COVID-19 test is what’s known as the “limit of detection.” This refers to the lower limit of how many viral copies must be present in a given quantity of a sample in order for the test to detect the presence of COVID-19. (The lower the limit of detection, the more sensitive and therefore better the test.) On November 25th, a third-party lab verified that Aptavid At Home™ (rapid home-use COVID-19 test kit that is in development has reached a limit of detection of 100,000 viral copies per milliliter. This beats the…

Vela Diagnostics is a New Jersey-based company that has created a Covid-19 testing system based on the “gold standard” of PCR amplification. Prior to the outbreak of Covid-19, Vela Diagnostics had established itself as a worldwide supplier of integrated life sciences and diagnostic solutions. The company had already been specializing in PCR technology and Nex-Generation Sequencing. Their philosophy is to focus on easy-to-use, fast, accurate, and cost-effective patient testing solutions.  Vela’s ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 tests for Covid-19 by analyzing nasal and oral swab samples. This approach uses an automated workflow system using the Sentosa™ SX101 instrument, the Sentosa™…

PerkinElmer is a Massachusetts-based medical company that is currently working on a number of Covid-19 solutions, including testing, therapeutics, and accelerated research.  PerkinElmer is a Massachusetts-based medical company that has developed a number of standardized solutions for the isolation and detection of Covid-19. In addition to testing, PerkinElmer is involved in accelerated virus research and therapeutic drug development. The company is more than 85 years old, and PerkinElmer was involved in the early development of things like atomic absorption spectrophotometers, aerial panoramic camera lenses, and computer-aided chemistry.  Today, PerkinElmer is an industry leader in fields like electronic laboratory notebooks ELNs,…

Mammoth Biosciences is a San Francisco based company that specializes in CRISPR technology for Covid-19 testing, and has developed a fast, efficient, and automated turnkey workstation diagnostics approach.  Mammoth Biosciences is a San Francisco-based company that uses CRISPR technology to detect the presence of Covid-19. Founded by a Nobel Prize winner, the company is “harnessing the diversity of nature to power the next generation of CRISPR products.” Using a proprietary discovery platform, Mammoth Biosciences can identify novel Cas proteins. Their Covid-19 testing approach is fast, automated, and efficient. Based around a turkey workstation, Mammoth’s CRISPR-based SARS-CoV-2 molecular assay uses automated…

With strong connections to Harvard and MIT, the Broad Institute provides clinics, nursing homes, and schools with reliable access to a reliable RT-PCR assay Covid-19 testing system.  Launched in 2004 by Harvard and MIT, the Broad Institute is a medical company that specializes in genomic technology, and they have created an RT-PCR assay Covid-19 testing system. This testing approach is targeted at hospitals, schools, and nursing homes. It is not intended for individual testing. The Broad Institute is already partnering with schools, nursing homes, and medical facilities across the municipality of Cambridge to deliver Covdid-19 testing services.  After the outbreak…

Quanterix is a Massachusetts company with an ultra-sensitive, versatile Covid-19 antigen test, and they are also the company behind the digital health solution Simoa.  Quanterix is a Massachusetts-based medical company that has developed a laboratory Covid-19 antigen test that uses an ultra-sensitive single-molecule assay to analyze a number of sample types, including nasal swabs, saliva, or finger-prick blood samples. Prior to the outbreak of Covid-19, Quanterix released the digital health solution Simoa, which allows researchers to closely examine critical biomarkers of infectious diseases. The company focuses on early detection, better prognoses, and enhanced treatment methods. Quanterix’s technology has applications in…

1 2 3 5